Emma Aarnio (E Aarnio)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 9

Top Venues

Biomedicines

British journal of clinical pharmacology

JMIR diabetes

Journal of internal medicine

University of Eastern Finland

University of Eastern Finland (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Eastern Finland

Finland

Postdoctoral researcher :: School of Pharmacy

Education History

University of Eastern Finland

Finland

PHD

University of Eastern Finland

Finland

MSC

University of Kuopio

Finland

MSC

Publications

Maria Kamusheva, Emma Aarnio, Miriam Qvarnström, Gaye Hafez, Sara Mucherino, Ines Potočnjak, Indre Trečiokiene, Jovan Mihajlović, Marie Ekenberg, Job F M van Boven, Francisca Leiva-Fernandez, null null
Pan-European survey on medication adherence management by healthcare professionals. British journal of clinical pharmacology (2024)
Martin Wawruch, Jan Murin, Tomáš Tesař, Miriam Petrova, Martina Paduchova, Denisa Celovska, Beata Havelkova, Michal Trnka, Lucia Masarykova, Sofa Dewi Alfian, Emma Aarnio
Reinitiation and Subsequent Discontinuation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers among New and Prevalent Users Aged 65 Years or More with Peripheral Arterial Disease. Biomedicines 11 (2) (2023)
Martin Wawruch, Jan Murin, Tomáš Tesař, Miriam Petrova, Martina Paduchova, Denisa Celovska, Beata Havelkova, Michal Trnka, Lucia Masarykova, Sofa Dewi Alfian, Emma Aarnio
Reinitiation and Subsequent Discontinuation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers among New and Prevalent Users Aged 65 Years or More with Peripheral Arterial Disease. Biomedicines 11 (2) (2023)
Martin Wawruch, Jan Murin, Tomáš Tesař, Martina Paduchova, Miriam Petrova, Denisa Celovska, Beata Havelkova, Michal Trnka, Lucia Masarykova, Sofa Dewi Alfian, Emma Aarnio
Gender Differences in Non-Persistence with Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers among Older Hypertensive Patients with Peripheral Arterial Disease. Biomedicines 10 (7) (2022)
Martin Wawruch, Jan Murin, Tomáš Tesař, Martina Paduchova, Miriam Petrova, Denisa Celovska, Petra Matalova, Beata Havelkova, Michal Trnka, Emma Aarnio
Adherence to Antiplatelet Medications among Persistent and Non-Persistent Older Patients with Peripheral Arterial Disease. Biomedicines 9 (12) (2021)
Martin Wawruch, Jan Murin, Tomáš Tesař, Martina Paduchova, Miriam Petrova, Denisa Celovska, Beata Havelkova, Michal Trnka, Emma Aarnio
Reinitiation and Subsequent Discontinuation of Antiplatelet Treatment in Nonpersistent Older Patients with Peripheral Arterial Disease. Biomedicines 9 (9) (2021)
Kari Jalkanen, Riia Järvenpää, Tanja Tilles-Tirkkonen, Janne Martikainen, Emma Aarnio, Reija Männikkö, Eeva Rantala, Leila J Karhunen, Marjukka Kolehmainen, Marja Harjumaa, Kaisa Poutanen, Miikka Ermes, Pilvikki Absetz, Ursula S Schwab, Timo A Lakka, Jussi Pihlajamäki, Jaana Lindström, null null
Comparison of Communication Channels for Large-Scale Type 2 Diabetes Risk Screening and Intervention Recruitment: Empirical Study. JMIR diabetes 6 (3) (2021)
Taika Suviranta, Johanna Timonen, Janne Martikainen, Emma Aarnio
The effects of reimbursement reform of antidiabetic medicines from the patients' perspective - a survey among patients with type 2 diabetes in Finland. BMC health services research 19 (1) (2019)
Emma Aarnio, R Huupponen, M J Korhonen
Important factors affecting the choice of an oral anticoagulant may be missed in database studies. Journal of internal medicine 283 (2) (2017)

Emma Aarnio.css-eqlu8i{font-size:small;padding-left:4px;} (E Aarnio)

Publication Activity (10 Years)

Top Topics

Top Venues

Emma Aarnio (E Aarnio)